Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Follow-On Study to Assess the Ongoing Safety of MBP8298 In Subjects With Secondary Progressive Multiple Sclerosis

NCT00870155 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00870155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00870155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Follow-On Study to Assess the Ongoing Safety of MBP8298 In Subjects With Secondary Progressive Multiple Sclerosis
Lead sponsor
Eli Lilly and Company
Phase
Phase 2/3
Overall status
Terminated
Start date
February 28, 2007
Completion date
September 30, 2009
Enrollment
546 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

secondary progressive multiple sclerosis